Verhagen Natascha, Zieringer Julia, Takors Ralf
Institute of Biochemical Engineering, University of Stuttgart, Stuttgart, Germany.
FEBS Open Bio. 2020 Dec;10(12):2791-2804. doi: 10.1002/2211-5463.13019. Epub 2020 Nov 11.
A major goal for process and cell engineering in the biopharmaceutical industry is enhancing production through increasing volumetric and cell-specific productivities (CSP). Here, we present 5'-deoxy-5'-(methylthio)adenosine (MTA), the degradation product of S-(5'-adenosyl)-L-methionine (SAM), as a highly attractive native additive which can boost CSP by 79% when added to exponentially growing cells at a concentration of 250-300 μm. Notably, cell viability and cell size remain higher than in non-treated cultures. In addition, cell cycle arrests first in S-, then in G2-phase before levelling out compared to non-treated cultivations. Intensive differential gene analysis reveals that expression of genes for cytoskeleton mediated proteins and vesicle transport is amplified by treatment. Furthermore, the interaction of MTA with cell proliferation additionally stimulated recombinant protein formation. The results may serve as a promising starting point for further developments in process and cell engineering to boost productivity.
生物制药行业中工艺和细胞工程的一个主要目标是通过提高体积生产率和细胞比生产率(CSP)来增加产量。在此,我们展示了5'-脱氧-5'-(甲硫基)腺苷(MTA),即S-(5'-腺苷基)-L-甲硫氨酸(SAM)的降解产物,它是一种极具吸引力的天然添加剂,当以250-300μm的浓度添加到指数生长的细胞中时,可使CSP提高79%。值得注意的是,细胞活力和细胞大小仍高于未处理的培养物。此外,与未处理的培养相比,细胞周期首先在S期停滞,然后在G2期停滞,之后趋于平稳。深入的差异基因分析表明,细胞骨架介导蛋白和囊泡运输相关基因的表达因处理而增强。此外,MTA与细胞增殖的相互作用还刺激了重组蛋白的形成。这些结果可能为工艺和细胞工程的进一步发展提供一个有前景的起点,以提高生产率。